Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:ATRI

Atrion (ATRI) Stock Price, News & Analysis

Atrion logo

About Atrion Stock (NASDAQ:ATRI)

Key Stats

Today's Range
$459.92
$459.92
50-Day Range
$456.25
$459.92
52-Week Range
$274.98
$503.24
Volume
N/A
Average Volume
23,283 shs
Market Capitalization
$809.46 million
P/E Ratio
43.23
Dividend Yield
1.91%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmic applications in the United States, Canada, Europe, and internationally. The company's fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. Its cardiovascular products comprise Myocardial Protection System that delivers fluids and medications, and mixes critical drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. The company's ophthalmic products consist of a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. It manufactures products for safe needle and scalpel blade containment; inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; and one-way and two-way pressure relief valves that protect sensitive electronics and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales force, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.

Receive ATRI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Atrion and its competitors with MarketBeat's FREE daily newsletter.

ATRI Stock News Headlines

Q3 2024 Nordson Corp Earnings Call
625,000% Gain
Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.
Atrion Corp (AN2.BE)
Atrion Reports Second Quarter 2024 Results
See More Headlines

ATRI Stock Analysis - Frequently Asked Questions

Atrion Co. (NASDAQ:ATRI) issued its quarterly earnings results on Thursday, August, 8th. The medical instruments supplier reported $0.23 earnings per share (EPS) for the quarter. The medical instruments supplier earned $48.77 million during the quarter. Atrion had a trailing twelve-month return on equity of 7.75% and a net margin of 10.60%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Atrion investors own include NVIDIA (NVDA), Tesla (TSLA), Advanced Micro Devices (AMD), Meta Platforms (META), JPMorgan Chase & Co. (JPM), Netflix (NFLX) and Visa (V).

Company Calendar

Last Earnings
8/08/2024
Today
11/02/2024
Next Earnings (Estimated)
11/05/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Health Care Supplies
Current Symbol
NASDAQ:ATRI
CUSIP
04990410
Employees
720
Year Founded
N/A

Profitability

Net Income
$19.41 million
Pretax Margin
12.22%

Debt

Sales & Book Value

Annual Sales
$181.60 million
Cash Flow
$19.68 per share
Book Value
$138.02 per share

Miscellaneous

Free Float
1,358,000
Market Cap
$809.46 million
Optionable
Not Optionable
Beta
0.69

Social Links

The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:ATRI) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners